Zenas BioPharma, Inc. (ZBIO)
Healthcare
Biotechnology
31.40 $
-2.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Zenas BioPharma, Inc. (ZBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -75 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -21 | 32 | -15 | -19 | -31 | -31 | -39 | -37 | -42 | -41 | -52 | -75 | -210 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.9 | 0.0 | 0.0 | -0.1 | -1.0 | |
| 0.7 | 1.0 | 1.1 | 0.9 | 1.5 | 2.8 | 5.5 | 5.4 | 6.0 | 7.3 | 7.6 | 9.2 | 30 | |
| -2.8 | -5.0 | 7.6 | 6.9 | 5.2 | 4.5 | 8.9 | -8.9 | 5.2 | -3.7 | 8.3 | -9.9 | -0.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 5.0 | 30 | 0.0 | 35 | |
| – | – | 0.0 | 0.0 | 0.0 | -27 | -3.7 | -86 | -112 | 40 | -93 | 32 | -134 | |
| – | – | – | – | – | – | – | – | – | 0.3 | – | 0.6 | – | |
| – | – | – | – | – | – | 0.0 | 0.0 | – | – | – | 268 | – | |
| 0.0 | 20 | 0.1 | -0.6 | 178 | 234 | 1.9 | 0.1 | 1.7 | 73 | 141 | 433 | 649 | |
| -21 | 52 | -15 | -20 | 147 | 176 | -40 | -123 | -153 | 72 | -4.9 | 390 | 304 | |
| -21 | 32 | -15 | -19 | -31 | -31 | -39 | -37 | -42 | -41 | -52 | -75 | -210 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.